Details for New Drug Application (NDA): 019520
✉ Email this page to a colleague
NDA 019520 describes TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in two NDAs. Additional details are available on the TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINER profile page.
The generic ingredient in TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINER is amino acids; dextrose; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; dextrose; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride profile page.
The generic ingredient in TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINER is amino acids; dextrose; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; dextrose; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride profile page.
Summary for 019520
| Tradename: | TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINER |
| Applicant: | Baxter Hlthcare |
| Ingredient: | amino acids; dextrose |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2.75%;5GM/100ML | ||||
| Approval Date: | Sep 23, 1988 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2.75%;10GM/100ML | ||||
| Approval Date: | Sep 23, 1988 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2.75%;15GM/100ML | ||||
| Approval Date: | Sep 23, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
